Nanding, Abdulrahman .
HRN: 15-57-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/07/2023
09/13/2023
IV
4.5g
Q6
Scrotal Abscess
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft TissueMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes